Napredna pretraga

Pregled bibliografske jedinice broj: 684025

A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study


Kolumbić Lakoš, Adela; Škerk, Višnja; Maleković, Goran; Dujnić Špoljarević, Tatjana; Kovačić, Dražen; Pasini, Miram; Markotić, Alemka; Magri, V.; Perletti, G.
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study // Journal of chemotherapy, 23 (2011), 6; 350-353 doi:10.1179/joc.2011.23.6.350 (međunarodna recenzija, članak, znanstveni)


Naslov
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study

Autori
Kolumbić Lakoš, Adela ; Škerk, Višnja ; Maleković, Goran ; Dujnić Špoljarević, Tatjana ; Kovačić, Dražen ; Pasini, Miram ; Markotić, Alemka ; Magri, V. ; Perletti, G.

Izvornik
Journal of chemotherapy (1120-009X) 23 (2011), 6; 350-353

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Chronic bacterial prostatitis; antibacterial therapy; pilot study

Sažetak
(CBP) is characterized by intense clinical symptoms, frequent relapse episodes and poor quality of life. Aggressive antibacterial therapy is warranted to eradicate the causative pathogens and to achieve a permanent cure. We administered a "switch-therapy" protocol to 30 patients showing severe CBP symptoms and two or more relapse episodes in the previous 12 months. Patients received intravenous azithromycin (500 mg/day) and ciprofloxacin (800 mg/day) for 3 days, followed by oral ciprofloxacin (1 g/day) for 25 days.Twenty-seven (90%) patients showed pathogen eradication at test-of-cure (TOC) visit. Five cases of infection relapse were detected at follow-up. At the TOC visit, 25 patients (83%) showed mild/absent symptoms, measured with the NIH-chronic prostatitis symptom index.These results indicate the efficacy of a "switch-therapy" protocol, based on combined azithromycin and ciprofloxacin. Comparative studies on larger CBP patient populations are warranted to confirm these encouraging results

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
143-1080002-0050 - Dijagnostika i liječenje bolesnika sa sindromom prostatitisa (Višnja Škerk, )
143-1430115-0103 - Imunoreakcije na hantaviruse i leptospire (Alemka Markotić, )

Ustanove
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati